ASK PINNACLE · QUESTIONS, EXPLANATIONS & NEXT STEPS
Early Clarity
Explore explanations, everyday questions and next steps connected with early clarity.
15,407 published answers · English · Page 415
CHOOSE THE QUESTION THAT MATTERS NOW
Explore this topic, one useful question at a time.
Causes & influences
The question links above are from this page. Topic groups can continue on later pages; the complete answer list and its pagination remain below.
Causes & influences
Cost-effectiveness of early therapy for self-regulation difficulties
Early therapy for self-regulation difficulties is among the most cost-effective developmental investments a payer can fund: high neuroplasticity, avoided downstream escalation, and parent-mediated leverage all raise return per rupee. Value is greatest when programmes are targeted, time-bound and tied to a consistent clinician-administered functional baseline — formed only at a Pinnacle centre.
Read the answer AnswerCost-effectiveness of early therapy for Sensory-Based Feeding Selectivity
Early therapy for Sensory-Based Feeding Selectivity (ICD-11 6B83) is cost-effective because it intercepts the steep downstream cost curve — faltering-growth workups, dietetic escalation, tube-feeding and entrenched mealtime conflict. Treating early shifts payer spend from crisis care to time-limited developmental support, amplified by caregiver coaching and tracked via a clinician-established functional baseline.
Read the answer AnswerCost-Effectiveness of Early Therapy for Sensory Processing Differences
Early therapy for Sensory Processing Differences is the more cost-effective path because the early years offer maximum neuroplasticity, timely support reduces costlier downstream demands on health, education and family systems, and a clinician-administered baseline lets payers tie spend to measured functional progress.
Read the answer AnswerCost-effectiveness of early therapy for Separation Anxiety Disorder
Early therapy for Separation Anxiety Disorder (ICD-11 6B05) in young children is highly cost-effective: it is brief, time-limited, heavily parent-delivered, and prevents the far costlier trajectory of untreated childhood anxiety. The strongest value comes from screening early and routing accurately, so funded therapy reaches children who genuinely need it.
Read the answer AnswerCost-effectiveness of early therapy for Social Communication Difficulties
Early therapy for Social Communication Difficulties (ICD-11 6A01.22) is highly cost-effective: intervening during peak plasticity reduces later, costlier support and improves school readiness. Value is greatest when therapy is structured, dose-appropriate, parent-extended and tracked against a reliable clinician-set baseline.
Read the answer AnswerCost-effectiveness of early therapy for Specific Learning Disability
Early therapy for Specific Learning Disability is highly cost-effective: it harnesses early-years neuroplasticity to achieve functional gains in fewer sessions, and displaces the far larger recurring costs of grade repetition, prolonged remediation and lost lifetime earnings. SpLD is reliably identified only once formal schooling begins, so the cost-effective stance before that is structured milestone monitoring.
Read the answer AnswerCost-effectiveness of early therapy for speech and language delay
Early therapy for speech and language delay is highly cost-effective: a modest, timely investment in the most plastic years reduces costlier remedial education, mental-health and productivity losses later. Value peaks when intervention is early, structured and measured against a consistent baseline.
Read the answer AnswerCost-effectiveness of early therapy for Stereotyped Movement Disorder
Early therapy for stereotyped movement disorder (ICD-11 6A06) is highly cost-effective: it uses peak neuroplasticity to reach functional outcomes in fewer sessions and reduces costly downstream supports, especially for self-injurious stereotypies. For payers the meaningful metric is cost per functional outcome over time, anchored by a clinician-administered baseline.
Read the answer AnswerCost-effectiveness of early therapy for Tourette Syndrome in young children
Early behavioural therapy for Tourette Syndrome in young children — chiefly CBIT and habit-reversal — is highly cost-effective for payers because it is time-limited, skills-based and offsets the costlier downstream burden of unmanaged tics, comorbid anxiety and medication. Value is greatest when commissioned as a behaviour-first pathway with baseline-to-outcome measurement.
Read the answer AnswerCost-Effectiveness of Early Therapy for Visual Impairment in Young Children
Early therapy for visual impairment in young children is highly cost-effective because the visual system is most plastic before age 3 and vision underpins motor, language and cognitive learning. Funding early, measurable intervention reduces downstream special-education, secondary-delay and caregiving costs. The clinical Developmental measurement supports care planning; diagnosis requires an appropriately qualified healthcare professional. under qualified clinician care.
Read the answer AnswerADHD prevalence and public-health burden among young children in India
ADHD (ICD-11 6A05) prevalence estimates among young children in India broadly range from about 2% to 8%, varying by age, setting and method. The greater public-health burden lies in under-recognition and late identification — making equitable developmental screening and reliable referral pathways the highest-return priority.
Read the answer AnswerAttachment Difficulties in India: prevalence and public-health burden
India has no robust national prevalence figure for Attachment Difficulties (ICD-11 6B44) among young children; the condition is under-recognised in routine data. The real public-health story is that its known risk drivers — institutional care, caregiver mental illness, neglect, poverty and migration — are widespread, making this a preventable, modifiable and inequity-deepening burden best addressed through population screen-and-support.
Read the answer AnswerPrevalence and public-health burden of Auditory Processing Difficulties in India
Reliable India-specific prevalence figures for Auditory Processing Difficulties in young children are not yet established; international estimates suggest roughly 2–5% of school-aged children. The Indian public-health burden is driven by late identification, diagnostic overlap and an audiological surveillance gap — making standardised listening-screening pathways the priority.
Read the answer AnswerAutism prevalence and public-health burden in young children in India
Indian community studies place autism prevalence near 1% of young children (roughly 1 in 100–125), broadly matching global estimates. The public-health burden is driven mainly by late identification, fragmented services and uneven access — gaps that population screening and early intervention close.
Read the answer AnswerCerebral Palsy in India: prevalence and public-health burden
Cerebral Palsy (ICD-11 8D20) is the commonest cause of childhood physical disability, with prevalence around 2–3 per 1,000 live births globally and comparable or higher figures in Indian community studies. Across India's large birth cohort this is a substantial burden, amplified by late identification, uneven early-intervention access, and co-occurring epilepsy, communication and feeding needs.
Read the answer AnswerChildhood Anxiety in India: Prevalence and Public-Health Burden
Childhood anxiety (ICD-11 6B0Z) is among the most common paediatric mental-health conditions, yet in India it is heavily under-counted in young children because national data skew toward adolescents and early presentations are misread as temperament. The public-health burden is cumulative — disrupted learning, school refusal, somatic symptoms and a known trajectory into adult anxiety — making early, non-stigmatising developmental screening the highest-yield policy lever.
Read the answer AnswerPrevalence and Public-Health Burden of Childhood Apraxia of Speech in India
There is no validated India-specific prevalence figure for Childhood Apraxia of Speech; international estimates suggest roughly 1–2 per 1,000 children. The true public-health burden lies in under-identification, the high intensity of therapy required, and a scarcity of national epidemiological data — making CAS a capacity- and surveillance-planning priority rather than a settled statistic.
Read the answer AnswerChildhood Epilepsy in India: Prevalence and Public-Health Burden
Epilepsy is among the commonest serious neurological conditions of childhood, with active-epilepsy prevalence in India around 3–11 per 1,000 and childhood-onset forms a large share. The defining burden is the treatment gap — many children, especially rural, never receive sustained care. Seizures require prompt medical referral first; developmental support follows. A clinical AbilityScore and diagnosis are formed only at a Pinnacle centre.
Read the answer AnswerChildhood sleep difficulties in India: prevalence and burden
Childhood sleep difficulties affect a substantial minority of young Indian children, with night waking and bedtime resistance most common. The burden spans child development, family wellbeing and avoidable service use, yet most cases are behavioural and respond to caregiver guidance — making brief screening within existing child-health touchpoints a high-yield, low-cost public-health opportunity.
Read the answer AnswerConduct-Dissocial Disorder: prevalence and public-health burden in young Indian children
Conduct-Dissocial Disorder (ICD-11 6C91) is rarely and deliberately not diagnosed in young children in India; broader NIMHANS surveys estimate ~7–10% of children and adolescents have a diagnosable condition. For planners, the public-health priority is early, non-stigmatising developmental identification, not early labelling.
Read the answer AnswerPrevalence and public-health burden of DCD in India
Developmental Coordination Disorder (ICD-11 6A04) affects an estimated 5–6% of school-age children internationally, implying several million affected children in India — the great majority undiagnosed. India's burden is driven by under-recognition rather than rarity, making screening and referral pathways the key public-health priority.
Read the answer AnswerPrevalence and Public-Health Burden of DLD in India
DLD (ICD-11 6A01.2) affects an estimated 7% of children — one to two per classroom. India has no single national study, but applied to its large under-six cohort this means millions of children, mostly undetected. The burden is driven by late identification, literacy and school failure, and higher mental-health load — all reducible through early speech-language intervention.
Read the answer AnswerPrevalence and public-health burden of Developmental Regression in India
Developmental regression is not separately counted in India's health statistics, so no exact national prevalence exists; it sits within the broader neurodevelopmental-disability burden, where Indian surveys place such disorders in the low single-digit percentages. Clinically it is a high-priority red flag that warrants prompt medical evaluation first. The public-health burden is driven by under-surveillance, late presentation and uneven access — making early, equitable identification a high-return investment.
Read the answer AnswerDevelopmental Trauma in India: Prevalence and Public-Health Burden
There is no single validated national prevalence figure for developmental trauma in young Indian children, because it describes the developmental impact of chronic early adversity rather than one coded diagnosis. The burden is best understood as scale: ~158 million under-sixes, with substantial exposure to adversity that disrupts early brain development — making it a preventable, high-return target for early-childhood policy.
Read the answer